Shandong Sinobioway Biomedicine Co Ltd (002581) — Long-term Investment Intensity
Shandong Sinobioway Biomedicine Co Ltd (002581) has a Long-term Investment Intensity of 13.6% as of September 2019. Long-term investments of CN¥528.81 Million represent 13.6% of total assets of CN¥3.88 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Shandong Sinobioway Biomedicine Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Shandong Sinobioway Biomedicine Co Ltd Long-term Investment Intensity (2015–2018)
This chart shows how Shandong Sinobioway Biomedicine Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 13.6%, reflecting long-term investments of CN¥528.81 Million against total assets of CN¥3.88 Billion CNY. For the complete balance sheet picture, see balance sheet size of Shandong Sinobioway Biomedicine Co Ltd.
Annual Long-term Investment Intensity for Shandong Sinobioway Biomedicine Co Ltd (2015–2018)
The table below presents the year-by-year Long-term Investment Intensity for Shandong Sinobioway Biomedicine Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read 002581 current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (CNY) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 10.1% | CN¥434.74 Million | CN¥4.29 Billion | ▼ -1.2 pp |
| 2017 | 11.3% | CN¥453.22 Million | CN¥4.00 Billion | ▼ -1.8 pp |
| 2016 | 13.1% | CN¥353.01 Million | CN¥2.69 Billion | ▲ +4.3 pp |
| 2015 | 8.8% | CN¥212.50 Million | CN¥2.42 Billion | — |